Cardiac drugs. Adenosine
Adenosine triphosphate (ATP) is a naturally occurring macroergic compound. It is synthesised in almost all body tissues by oxidative phosphorylation and in the process of carbohydrate breakdown.
As a part of complex therapy of muscular dystrophy and atrophy; for the relief of paroxysms of supraventricular tachycardia; in peripheral vasospasm (intermittent limping, Raynaud's disease, thromboangiitis obliterans).
In central, peripheral and mixed forms of hereditary retinitis pigmentosa.
Administer Sodium adenosintriphosphate-Darnitsa intramuscularly or intravenously.
For the treatment of muscular dystrophy, peripheral circulation disorders, prescribe 1 ml intramuscularly once per day in the first 2–3 days, in the following days — 1 ml twice per day or 2 ml once per day. The treatment course is 30–40 days. Repeat the course in 1–2 months.
For hereditary retinitis pigmentosa, inject 5 ml intramuscularly twice per day with an interval of 6–8 hours, daily for 15 days. If necessary, the courses can be repeated at intervals of 8–12 months.
For the relief of supraventricular tachyarrhythmias administer 1–2 ml intravenously over 5–10 seconds (the effect is observed after 20–40 seconds). Repeat the same dose after 2–3 minutes.
There is no experience of use in children, hence the drug is contraindicated in this age category.